William Rosenberg
Vorstandsvorsitzender bei iQur Ltd.
Profil
William Rosenberg is the founder of iQur Ltd., a company he founded in 2003 where he holds the title of Director, Chief Executive & Scientific Officer from 2007 to present.
He is currently a Director at University College London.
Mr. Rosenberg's former positions include being a Principal at the University of Oxford and the University of Southampton.
Mr. Rosenberg received his undergraduate degree from the University of Cambridge.
Aktive Positionen von William Rosenberg
| Unternehmen | Position | Beginn |
|---|---|---|
iQur Ltd.
 iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Vorstandsvorsitzender | 01.02.2007 |
| University College London | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von William Rosenberg
| Unternehmen | Position | Ende |
|---|---|---|
| University of Oxford | Corporate Officer/Principal | - |
| The University of Southampton | Corporate Officer/Principal | - |
Ausbildung von William Rosenberg
| University of Cambridge | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Health Technology |
